Make Health My Homepage
More Ways to Get Health!
gift newsletter igoogle healthyvoice
Diabetes

News & Headlines

Genome Mapped for Type 2 Diabetes

February 5, 2010

FRIDAY, Feb. 5 (HealthDay News) — Scientists have completed a map of areas of the human genome that control which genes are switched on or off in type 2 diabetes, a finding that may advance understanding of the genetic basis of this and other common diseases.

“Most of the human genome is uncharted territory — entire stretches of sequence with no clear function or purpose,” study co-senior author Jason Lieb, an associate professor of biology at the University of North Carolina at Chapel Hill, said in a news release. Read More


Victoza Sanctioned for Type 2 Diabetes

January 26, 2010

TUESDAY, Jan. 26 (HealthDay News) — Victoza (liraglutide) has been approved to treat type 2 diabetes in some adults, the U.S. Food and Drug Administration said in a news release.

But the agency warned that the once-daily injection shouldn’t be used as an initial (first-line) treatment until additional studies are completed, since the drug may cause thyroid tumors or a rare disease called medullary thyroid cancer. People at risk for this type of cancer shouldn’t use the drug, the FDA stressed. Read More


Red-Grape Compound May Improve Diabetes

October 22, 2009

THURSDAY, Oct. 22 (HealthDay News) — New research provides further insight into how a health-boosting compound found in red grapes may help the body fend off type 2 diabetes.

But scientists have only seen the effect in mice who received injections in the brain, and no evidence has emerged that consuming red wine or other products made with grapes will alleviate the blood sugar disease.

The findings do tell scientists about how the compound known as resveratrol works on the brain, said senior study author Roberto Coppari. Read More


Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes

September 28, 2009

MONDAY, Sept. 28 (HealthDay News) — Women with type 2 diabetes have a 26 percent increased risk of developing atrial fibrillation, a potentially life-threatening irregular heartbeat, new findings suggest.

The overall incidence of atrial fibrillation was 3.6 percent among people with type 2 diabetes, while the rate for people without the metabolic condition was only 2.5 percent, according to the study, which will be published in the October issue of Diabetes Care. Read More


Mediterranean Diet May Be Best for Type 2 Diabetes

September 1, 2009

MONDAY, Aug. 31 (HealthDay News) — The Mediterranean diet, long touted as a healthy eating plan, may help people with type 2 diabetes stay off blood sugar-lowering medications, as well as help them lose weight and lower cardiovascular risk factors.

Those are the major findings from Italian researchers who found that while 70 percent of people with type 2 diabetes following a low-fat diet eventually needed diabetes medications, just 44 percent of those following the Mediterranean diet needed such drugs. Read More


Mediterranean Diet Can Stave Off Need for Diabetes Drugs

August 31, 2009
mediterranean-diet

(Getty Images)
By Heather Mayer

MONDAY, Aug. 31, 2009 (Health.com) — Studies already suggest that the Mediterranean diet—rich in fish, fruits, nuts, and olive oil—can prevent second heart attacks, delay Alzheimer’s disease, and maybe even lower your cancer risk.

Now, new research says the Mediterranean diet may also be a winning solution for people with type 2 diabetes. Compared to people on a low-fat diet, those with type 2 diabetes who ate a Mediterranean diet lost more weight and went longer without blood-sugar-lowering medication, according to a study published this week in Annals of Internal Medicine. Read More


Sex Hormone Protein May Predict Type 2 Diabetes

August 6, 2009

WEDNESDAY, Aug. 5 (HealthDay News) — A protein that carries and activates sex hormones throughout the body may also predict those at high risk of developing type 2 diabetes, a new study finds.

The protein, called sex hormone-binding globulin (SHBG), regulates the levels of testosterone and estrogen in the blood. Researchers suspect it also plays a role in the development of type 2 diabetes. Read More


Onglyza Sanctioned for Type 2 Diabetes

August 3, 2009

FRIDAY, July 31 (HealthDay News) — Onglyza (saxagliptin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Friday.

The once-daily pill is meant to be combined with proper diet and exercise to help control blood sugar, the agency said in a news release. It’s among a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which are designed to have the pancreas produce more insulin after a person eats. Insulin helps the body maintain normal blood sugar levels. Read More


Cycloset Approved for Type 2 Diabetes

May 7, 2009

WEDNESDAY, May 6 (HealthDay News) — Cycloset (bromocriptine), a drug that takes the novel approach of managing blood sugar via the brain, has been approved by the U.S. Food and Drug Administration, maker VeroScience Inc. said Wednesday.

The drug, previously prescribed in higher amounts to treat Parkinson’s disease, targets a brain chemical that ultimately is involved in regulating metabolism, reports the Associated Press. Read More


Saliva Test Could Monitor Type 2 Diabetes

January 20, 2009

TUESDAY, Jan. 20 (HealthDay News) — Scientists say they are on the verge of developing a saliva test for monitoring type 2 diabetes, which might someday replace invasive blood tests.

For the first time, researchers from Oregon and India have identified proteins in saliva that appear more frequently in people with diabetes than in non-diabetics. Using these proteins, they are working to develop a test to monitor and perhaps diagnose the condition. Read More



Previous type 2 Diabetes Stories


Continuously updated headlines delivered right to your computer
Text Size: Decrease Increase

Advertisement
Close
  • Social Web
  • E-mail
Site powered by WordPress.com VIP